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HEALTH AND MEDICINE

Sustained oxygenation accelerates diabetic wound
healing by promoting epithelialization and
angiogenesis and decreasing inflammation
Ya Guan1†, Hong Niu1†, Zhongting Liu1, Yu Dang1, Jie Shen2, Mohamed Zayed3,
Liang Ma4, Jianjun Guan1*

INTRODUCTION

Diabetes is a chronic metabolic disorder affecting 34.2 million
people across the United States (1). One of the common complications of diabetes is diabetic foot ulcers (DFUs). Roughly 25% of
diabetic patients experience DFU (2), which causes prolonged pain,
decreased vitality, and possibly the need for foot amputation.
Conservative medical care for DFU, such as wound off-loading, wound
debridement, and infection control (3), has inconsistent outcomes
and is associated with undesired side effects (3, 4). Stable and safe
treatments for chronic, nonhealing diabetic wounds could benefit
millions of people.
Cutaneous diabetic wound healing is a complex process with three
overlapping phases: inflammation, proliferation, and remodeling (5).
Immediately after the precipitating injury, impaired vasculature
impedes oxygen delivery to the wound, creating a hypoxic environment
around the wound (5–7). This hypoxia is exacerbated by the recruitment of inflammatory cells with high oxygen consumption (8, 9).
Although acute hypoxia promotes cell proliferation and initiates
tissue repair, long-term oxygen deprivation in chronic wounds impairs
the healing process via inhibition of angiogenesis, reepithelialization,
and extracellular matrix (ECM) synthesis (10). Thus, enhanced wound
tissue oxygenation is key to chronic wound healing.
In the past few decades, diabetic wound healing has been clinically
facilitated by oxygenation, particularly hyperbaric oxygen therapy
(HBOT) (11). HBOT delivers 100% oxygen at 2 to 3 atm for 1 to
2 hours per treatment to patients with DFU. In some cases, HBOT
promoted diabetic wound healing after 40 or more treatments
(12, 13), while in other studies, it did not show beneficial effects
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(11, 14). Overall, the therapeutic efficacy of HBOT is widely considered
to be inconsistent and unsatisfactory (15, 16). This poor performance
mainly results from HBOT’s inability to continuously provide sufficient
oxygen to the wounds because the oxygen content in the poorly
vascularized wounds decreases quickly following the treatment (17).
Moreover, as a systemic oxygen delivery strategy, HBOT may create
risks of tissue hyperoxia, such as oxygen toxicity seizure (17, 18).
Several previous reports have developed oxygen-generating
systems that are implanted locally to increase the oxygen concentration
in wound beds to address the limitations of systemic oxygenation.
These oxygen-generating systems were based on H2O2 (hydrogen
peroxide) (19), calcium peroxide (20, 21), and perfluorocarbon (22). The
localized oxygenation can avoid systemic hyperoxia while accelerating
chronic wound healing. However, these oxygenation systems typically
release oxygen for only 3 to 6 days (20, 22), which is not long enough for
diabetic wound healing. In addition, these systems cannot quickly release
sufficient oxygen to relieve hypoxia (20, 21). Oxygen is required for
important events, including angiogenesis, granulation, reepithelialization,
and ECM synthesis, that often take 2 weeks or longer (6, 23, 24). Hence,
it is critical to develop oxygen-generating systems that continuously
oxygenate the wound bed for long periods to accelerate healing.
Here, we present an oxygen-generating system based on oxygen-
release microspheres (ORMs) and an injectable, fast-gelling, and
reactive oxygen species (ROS)–scavenging hydrogel (ROSS gel). The
microspheres quickly release enough oxygen to support cell survival
under hypoxia and sustain the release of oxygen for at least 2 weeks.
Unlike most current oxygen-generating systems that first release toxic
H2O2 into the tissue environment and then rely on its decomposition
to release oxygen, the designed ORMs directly release oxygen. The
injectable and fast-gelling hydrogel is used as a carrier to deliver the
microspheres into wounds and quickly immobilize them there, with
a high tissue retention rate. The hydrogel has a relatively high water
content, enabling it to maintain a moist environment surrounding the
wound (25). Because it can also scavenge ROS, the oxygen-generating
system can capture excessive ROS in diabetic wounds. While ROS
play a crucial role in regulating biological and physiological processes,
1 of 14
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Nonhealing diabetic wounds are common complications for diabetic patients. Because chronic hypoxia prominently
delays wound healing, sustained oxygenation to alleviate hypoxia is hypothesized to promote diabetic wound
healing. However, sustained oxygenation cannot be achieved by current clinical approaches, including hyperbaric
oxygen therapy. Here, we present a sustained oxygenation system consisting of oxygen-release microspheres
and a reactive oxygen species (ROS)–scavenging hydrogel. The hydrogel captures the naturally elevated ROS in
diabetic wounds, which may be further elevated by the oxygen released from the administered microspheres. The
sustained release of oxygen augmented the survival and migration of keratinocytes and dermal fibroblasts,
promoted angiogenic growth factor expression and angiogenesis in diabetic wounds, and decreased the
proinflammatory cytokine expression. These effects significantly increased the wound closure rate. Our findings
demonstrate that sustained oxygenation alone, without using drugs, can heal diabetic wounds.
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elevated ROS in diabetic wounds can damage cells (26, 27). In this
study, we assessed the therapeutic efficacy of the oxygen-generating
system in promoting wound closure. We also elucidated the underlying
mechanisms of how sustained oxygen release promotes diabetic
wound healing. While previous studies have shown that short-term
oxygen release facilitated wound closure, the underlying mechanisms
were not fully clear and were mainly attributed to wound angiogenesis
(28). We comprehensively evaluated the effect of sustained oxygen
release on skin cell survival, migration, and paracrine effects; intracellular oxygen content; prosurvival pathways; tissue angiogenesis;
and tissue inflammation and oxidative stress.
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and figs. S2 to S4). However, the ROS level was similar to the
normoxia group (P > 0.05 for all cell types). These results, together with
dsDNA results, show that the released oxygen did not overproduce
ROS and induce cell apoptosis.
To determine whether the released oxygen could increase the
migration of keratinocytes and dermal fibroblasts, a scratch assay
was performed. After 48 hours of incubation under 1% oxygen, the
migration rates of HaCaT cells and HDFs were significantly higher
in the ORM groups than in the control groups without ORMs
(P < 0.001; Fig. 1, L, M, O, and P). These results demonstrate that
the released oxygen promoted skin cell migration under hypoxia.
We further elucidated the effect of released oxygen on skin cell
expression of angiogenic growth factors under hypoxic conditions.
RESULTS
For HaCaT cells, treatment with ORMs significantly increased the
Microspheres released molecular oxygen continuously
expression of vascular endothelial growth factor-A (VEGFA; P < 0.05)
The ORMs had a core-shell structure (Fig. 1A), in which the core and basic fibroblast growth factor (FGF2; P < 0.001) (Fig. 1N). For
was a stable polyvinylpyrrolidone (PVP)/H2O2 complex. The shell HDFs, the released oxygen significantly augmented the expression
was bioeliminable and bioconjugatable poly(N-isopropylacrylamide- of platelet-derived growth factor-B (PDGFB; P < 0.001) and FGF2
co-2-hydroxyethyl methacrylate-co-acrylate-oligolactide-co-N- (P < 0.001) (Fig. 1Q). These growth factors play critical roles in
acryloxysuccinimide) [poly(NIPAAm-co-HEMA-co-AOLA-co-NAS)] reepithelialization and angiogenesis during cutaneous wound healing
(fig. S1). The microspheres had a diameter of ~5 m (Fig. 1B). The (33–36). It remains to be investigated whether the up-regulation of
core-shell structure was confirmed by fluorescent images (Fig. 1C). these growth factors is associated with a signaling cascade, which
The shell of the microspheres was conjugated with catalase to timely can be activated by the released oxygen.
convert the H2O2 in the released PVP/H2O2 into molecular oxygen
In chronic wounds, the hypoxic environment impairs angiogenesis,
and keep H2O2 from exiting the microspheres and causing toxicity resulting in delayed wound healing (37). To evaluate the potential
concerns. A layer of catalase was conjugated on the shell, as evidenced of released oxygen in promoting angiogenesis under hypoxia, we
by the fluorescence signal of fluorescein isothiocyanate (FITC)– conducted an in vitro endothelial tube formation assay (Fig. 1R).
labeled catalase (Fig. 1D).
The ORM was injected into three-dimensional (3D) collagen
To determine the oxygen-release kinetics, we used an oxygen- constructs seeded with HAECs. Following 16 hours of culture under
sensitive luminophore, Ru(Ph2phen3)Cl2, whose fluorescence intensity 1% oxygen, the HAECs assembled with a significantly greater number
is linearly proportional to the oxygen content (29, 30). The ORMs of lumens, exhibiting an ~2.5-fold increase in lumen density than
were able to continuously release oxygen during the 2-week experi- the control group (P < 0.01; Fig. 1, S and T).
mental period (Fig. 1E). The oxygen level reached above 5% after
2 days of release, and it was maintained above 10% from days 3 to 14. Continuous oxygenation by released oxygen elevated
After the 2-week study period, the release medium contained less intracellular oxygen content and adenosine triphosphate
than 10 M H2O2, as measured by a quantitative peroxide assay kit. content and activated extracellular signal–regulated kinase
This concentration will not cause cell apoptosis (31).
1/2 and heme oxygenase 1 signaling
To explore how continuous oxygenation by released oxygen increased
Continuous oxygenation of skin cells by released oxygen
skin cell survival and migration, we used electron paramagnetic
promoted skin cell survival, migration and paracrine effects, resonance (EPR) to measure the intracellular oxygen content in
and endothelial lumen formation under hypoxia in vitro
HaCaT cells (Fig. 2A). After 24 hours of treatment with ORMs
In diabetic wounds, hypoxia is a major factor compromising cell under 1% oxygen, the intracellular oxygen content was 2.5 times that of
survival and migration, leading to slow wound healing (6, 30, 32). cells without ORM treatment (Fig. 2, B and C). To determine whether
To evaluate whether oxygen released from ORMs was able to improve the elevated intracellular oxygen content promoted cellular energy
cell survival under hypoxia, we incubated human keratinocytes production, we measured the intracellular adenosine triphosphate
(HaCaT cells), human dermal fibroblasts (HDFs), and human arte- (ATP) level in HaCaT cells. The ATP level in the group treated with
rial endothelial cells (HAECs) with the ORMs under 1% oxygen. All ORMs was significantly increased over that in the group without
three cell types exhibited a significantly higher double-stranded DNA ORM treatment (P < 0.01; Fig. 2D), demonstrating that increased
(dsDNA; characteristic of live cells) content than the corresponding cell survival and migration by continuous oxygenation is associated
control groups without ORMs (P < 0.001 for HaCaT cells and HAEC with increased intracellular oxygen content and energy generation.
and P < 0.01 for HDF; Fig. 1, F to H). These results demonstrate
Oxygen-mediated wound healing is associated with various
that the released oxygen effectively increased skin cell survival signaling molecules or pathways, such as mitogen-activated protein
under hypoxia. One of the concerns of oxygen treatment is the kinase (MAPK) (9), transforming growth factor–1 (38), heme
overproduction of ROS. To characterize ROS expression in the three oxygenase 1 (HO-1) (39), and heat shock proteins (40). Many
cell types, we used an ROS-sensitive dye, CM-H2DCFDA, to stain researchers have confirmed that HBOT activates MAPK pathway,
the cells cultured under normoxia, hypoxia (1% oxygen), and hypoxia which modulates cellular responses such as proliferation and migrawith the addition of ORMs (hypoxia/ORM group). The released tion (9). Thus, we investigated whether the ORMs can increase
oxygen in the hypoxia/ORM group substantially increased the ROS MAPK activity to promote the survival and migration of skin cells.
level in the three cell types compared to the hypoxia group (Fig. 1, I to K, We performed Western blot analysis using HDF to determine
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Fig. 1. ORMs continuously release oxygen and regulate skin cell behaviors in vitro. (A) Schematic illustration of ORMs and its oxygen-release mechanism. (B) Scanning
electron microscopy image of ORM. (C) Fluorescent image of ORM. (D) Fluorescent image of ORM after catalase (labeled with FITC) conjugation. Color of FITC was adjusted.
(E) Oxygen-release kinetics of ORMs. n = 8. (F to H) Double-stranded DNA (dsDNA) content of HaCaT cells (n = 5) (F), human dermal fibroblasts (HDFs; n = 5) (G), and human
arterial endothelial cell (HAECs; n = 3) (H) cultured under hypoxia. (I to K) ROS content in HaCaT cells (n = 10) (I), HDFs (n = 6) (J), and HAECs (n = 8) (K) cultured under
normoxia, hypoxia, or hypoxia with ORM. (L and M) Migration of HaCaT cells cultured under hypoxia. n = 4. (N) Gene expression of PDGFB, VEGFA, and FGF2 in HaCaT cells
cultured under hypoxia. n ≥ 3. (O and P) Migration of HDFs cultured under hypoxia. n = 4. (Q) Gene expression of PDGFB, VEGFA, and FGF2 in HDFs cultured under hypoxia.
n ≥ 3. (R) Schematic illustration of HAEC tube formation assay. (S and T) Tube formation (S) and tube density (T) of HAECs cultured under hypoxia for 16 hours. Scale bars,
50 m. *P < 0.05, **P < 0.01, and ***P < 0.001. NS, not significant; DAPI, 4′,6-diamidino-2-phenylindole.
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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whether the extracellular signal–regulated kinase (Erk1/2) axis, one of
the major cascades of the MAPK pathway, was activated in response to
the released oxygen. The results demonstrated that Erk1/2 phosphoryl
ation was increased after the cells were treated with ORMs under
1% oxygen (Fig. 2E). In addition, we investigated whether HO-1, a
stress-inducible and cytoprotective protein, was up-regulated after
treatment with released oxygen under hypoxia. In the ORM group,
the HO-1 expression was more pronounced than in the control
group (Fig. 2E). Together, the above results reveal that continuous
oxygenation by released oxygen activated the Erk1/2 and HO-1
pathway, leading to enhanced cell survival and migration.
The injectable, thermosensitive, and ROS-scavenging
hydrogel delivered ORMs and protected skin cells
under oxidative stress
To deliver the ORMs to diabetic wounds and largely retain them in
the tissue, we synthesized an injectable and thermosensitive hydrogel
with a fast gelation rate. The hydrogel was also designed to capture
up-regulated ROS in diabetic wounds to protect skin cells from
ROS-induced apoptosis. This hydrogel may also eliminate ROS
generated by excessive oxygen release. The hydrogel was synthesized
by copolymerizing NIPAAm, HEMA, and 4-(acryloyloxymethyl)-
phenylboronic acid pinacol ester (Fig. 3, A and B, and fig. S5). The
hydrogel solution [6 weight % (wt%)] had a gelation temperature of
17°C, and it was injectable at 4°C. After being transferred into a
37°C water bath, the hydrogel solution solidified within 6 s (Fig. 3C).
The mixture of hydrogel solution and ORMs (40 mg/ml) remained
injectable at 4°C and gelled quickly (6 s) at 37°C (Fig. 3C).
The ROS-scavenging capability of the hydrogel was evaluated in
terms of its consumption of hydroxyl radical (HO•) and superoxide
(O2•−) and by the hydrogel weight loss induced by H2O2. After
incubation with HO• for 1 day, the hydrogel scavenged markedly more
HO• than the non–ROS-responsive control hydrogel (P < 0.001;
Fig. 3D). Similarly, the hydrogel eliminated eightfold more O2•− than
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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the control hydrogel after incubation for 1 day (P < 0.001; Fig. 3E).
The hydrogel gradually lost weight in H2O2 solution during the
4-week experimental period (Fig. 3F). In contrast, the hydrogel did
not show substantial weight loss in Dulbecco’s phosphate-buffered
saline (DPBS) without H2O2.
To evaluate the efficacy of the hydrogel in protecting skin cell
survival under pathological oxidative stress, HaCaT cells were seeded
on the hydrogel surface in the presence of 100 M H2O2, and the
cell viability was quantified (Fig. 3G). The non–ROS-responsive
hydrogel was used as a control. We found that HaCaT cells seeded
on the hydrogel did not undergo substantial apoptosis in 100 M
H2O2 at 48 hours and even proliferated at 72 hours. However, HaCaT
cells on the non–ROS-responsive hydrogel had significantly lower
viability than the ROS-responsive hydrogel (P < 0.001 at 48 and
72 hours), with only ~50% viability at 72 hours (Fig. 3H). These
results demonstrate that the ROS-responsive hydrogel was able to
protect keratinocytes from apoptosis caused by pathological oxidative stress.
Diabetic wound closure was accelerated by continuous
oxygenation and ROS scavenging
To determine whether continuous oxygenation and ROS scavenging
can accelerate diabetic wound healing, we administered the hydrogel with ORMs (Gel/ORM group) onto full-thickness excisional
wounds on diabetic mice (Fig. 4A). Wounds without treatment (No
treatment group) and wounds treated with hydrogel alone (Gel
group) were used as controls. The wounds treated with Gel/ORM
had a greater closure rate than the No treatment and Gel groups
(Fig. 4B). By day 16, the wound size in the Gel/ORM group was
reduced to 10.7%, significantly smaller than that in the Gel (30.4%)
and No treatment groups (52.2%) (P < 0.01; Fig. 4C). Notably, the
wound size in the Gel group was substantially smaller than in the
No treatment group, demonstrating that the Gel alone promoted
wound closure.
4 of 14
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Fig. 2. ORMs elevate intracellular oxygen content and ATP content and activate HO-1 and Erk1/2 pathways under hypoxia. (A to C) Intracellular oxygen content
measured by EPR. Keratinocytes (HaCaT cells) were incubated with lithium phthalocyanine (LiPc) nanoparticles for endocytosis and then cultured under 1% oxygen conditions
(with or without ORM) for 24 hours. n = 3 for each group. *P < 0.05. (D) Intracellular ATP content in HaCaT cells measured by an ATP assay kit. Cells were cultured under 1%
oxygen conditions (with or without ORM) for 24 hours. **P < 0.01. (E) Immunoblotting of HO-1 and phosphorylated Erk1/2 (p-Erk1/2) in dermal fibroblasts cultured under
hypoxic conditions for 48 hours. t-Erk1/2 was used as the internal reference. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as a loading control.
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Reepithelialization is crucial in wound healing. To evaluate
the rate of reepithelialization, we used cytokeratin 14 (K14) and
cytokeratin 10 (K10), two markers for basal keratinocytes and spinous
keratinocytes, respectively, to stain tissue sections harvested on
days 8 and 16. On day 8, in the Gel/ORM group, the wound gap was
nearly enclosed by a complete layer of basal keratinocytes (K14+),
while in the No treatment and Gel groups, keratinocyte migration
was much slower (Fig. 4D and fig. S6). In addition, compared to the
No treatment and Gel groups, the Gel/ORM group formed a more
mature spinous layer composed of K10+ keratinocytes. On day 16,
the migration of basal keratinocytes was complete, and proliferation
and differentiation were ongoing in the No treatment and Gel groups.
In contrast, reepithelialization was fully complete in the Gel/ORM
group, as evidenced by a clear stratified epithelium (Fig. 4D and fig.
S6). On both day 8 and day 16, K14 staining of the hair follicles in
the basal layer of the epidermis (Fig. 4E) revealed a significantly
increased hair follicle density in the Gel/ORM group than in the No
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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treatment and Gel groups (P < 0.01; Fig. 4F). These results demonstrate that the continuous oxygenation by released oxygen, together
with ROS scavenging, effectively accelerated keratinocyte migration
and hair follicle formation, consequently promoting reepithelialization
of the diabetic wounds.
Epidermal thickness, another indicator of wound healing, increases
during the initial inflammatory and proliferative stages and then
decreases during the remodeling stage (41). On day 8, the wounds
treated with Gel/ORM exhibited the thickest epidermis. By day 16,
it had become the thinnest (P < 0.001; Fig. 4, G and H), suggesting
that the continuous oxygenation and ROS scavenging facilitated the
wound’s healing progressions from the inflammatory and proliferative
stages to the remodeling stage.
To determine whether the accelerated wound closure was
associated with scar formation, we performed picrosirius red staining
for collagens in the wounds. On day 16, the Gel/ORM group had a
significantly lower total collagen content than the No treatment
5 of 14
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Fig. 3. ROS-scavenging hydrogel protects skin cells under oxidative stress by consuming hydroxyl radicals and superoxides. (A) ROS-scavenging (ROSS) hydrogel
capable of scavenging ROS in chronic wounds or generated from released oxygen or PVP/H2O2. (B) Synthesis and ROS-scavenging mechanism of ROSS hydrogel. BPO,
benzoyl peroxide. (C) Injectability and gelation of ROSS hydrogel (Gel) and Gel/ORM construct. (D) Scavenging effect on hydroxyl radicals of ROSS gel and non–ROS-
responsive gel (Control) (n = 4). (E) Scavenging effect on superoxide of ROSS gel and non–ROS-responsive gel (Control) (n = 3). (F) Degradation of ROSS gel at 37°C for
4 weeks in DPBS with 0 and 50 mM H2O2. (G) Schematic illustration of an in vitro model for skin cell survival on gels under 100 M H2O2 to mimic the in vivo cell environment
under oxidative stress. Non–ROS-responsive gel was used as a control. (H) Cell viability of HaCaT cells at 48 and 72 hours on control gel and ROSS gel (normalized to the
initial cell viability on each gel). n ≥ 6. *P < 0.05 and ***P < 0.001. Photo credit: Hong Niu, Washington University in St. Louis.
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group (P < 0.05; Fig. 4, I and J). In addition, a significantly higher
collagen I/III ratio was found for the Gel/ORM group than the No
treatment and Gel groups (P < 0.05; Fig. 4K). Compared to the
control groups, this collagen I/III ratio was closer to that of uninjured skin. The reduced collagen deposition and higher collagen I/III
ratio demonstrate that the enhanced wound healing did not induce
scar formation (42, 43).

Fig. 4. ORMs encapsulated in ROS-scavenging hydrogel accelerate wound
healing in db/db mice. (A) Schematic illustration of the design of animal experiments
to test the therapeutic effect of ROSS gel (Gel) and ORMs in a db/db mouse model.
(B) Representative images of the wounds treated with or without Gel and ORMs for
16 days. (C) Wound size change during 16 days of post wounding. Wound size at
each time point was normalized to day 0. n ≥ 8. (D) Immunofluorescence staining
of cytokeratin 10 (K10, green) and cytokeratin 14 (K14, red) for the wounds at days 8
and 16. Scale bars, 200 m. (E) Immunofluorescence staining of K14 (red) in the
wounded region at days 8 and 16. Scale bars, 50 m. (F) Quantification of hair follicle
density in the wounded region at days 8 and 16. (G) Hematoxylin and eosin staining
of the wounded skin at days 8 and 16. Scale bars, 500 m. (H) Quantification of
epidermal thickness. Epidermal thickness was calculated in the region where wound
was closed. (I) Picrosirius red staining of the wounded skin at day 16. Scale bar, 50 m.
(J) Quantification of total collagen deposition at day 16. (K) Quantification of collagen I/III
ratio at day 16. *P < 0.05, **P < 0.01, and ***P < 0.001. Photo credit: Ya Guan and
Hong Niu, Washington University in St. Louis.
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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Continuous oxygenation and ROS scavenging in diabetic
wounds stimulated angiogenic growth factor expression
and angiogenesis
To determine whether continuous oxygenation and ROS scavenging affect the expression of angiogenic growth factors in diabetic
wounds, real-time reverse transcription polymerase chain reaction
(RT-PCR) was performed using wound tissues extracted 8 days
after surgical wounding (Fig. 5, E and F). Among different angiogenic growth factors, Pdgfb expression was significantly increased
in both the Gel and Gel/ORM groups (P < 0.01; Fig. 5E), with the
Gel/ORM group showing substantially greater expression than the
Gel group (P > 0.05). Notably, the Gel/ORM group exhibited significantly higher Vegfa expression than the Gel and No treatment
groups (P < 0.01; Fig. 5F).
To evaluate whether continuous oxygenation and ROS scavenging stimulated angiogenesis in the diabetic wounds, we quantified
the capillary densities in the Gel/ORM, Gel, and No treatment
groups at middle stage (day 8) and late stage (day 16) of the wound
healing. At both stages, the Gel group had a significantly higher density
of capillaries than the No treatment group, demonstrating that ROS
scavenging promoted diabetic wound angiogenesis (Fig. 5, G and H).
The simultaneous ROS scavenging and continuous oxygenation in
the Gel/ORM group further significantly stimulated angiogenesis
(Fig. 5, G and H).
Continuous oxygenation and ROS scavenging in diabetic
wounds alleviated oxidative stress, inflammation,
and proinflammatory cytokine expression
The ROS-scavenging hydrogel decreased the ROS content in diabetic
wounds (Fig. 6, A and C). On both day 8 and day 16, the ROS+ cell
density was markedly lower in the Gel group than in the No treatment group (P < 0.001). Although the continuous oxygenation of the
diabetic wounds may have led to the formation of ROS, the hydrogel
was able to capture it. On days 8 and 16, the Gel and Gel/ORM
6 of 14
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Continuous oxygenation and ROS scavenging in diabetic
wounds promoted cell proliferation and metabolism
To understand the role of continuous oxygenation and ROS scavenging in diabetic wound healing at the cellular level, we examined cell
proliferation and metabolism in the wounds. Compared to the No
treatment group on both day 8 and day 16, the ROS-scavenging activity of the hydrogel alone had significantly increased the density
of Ki67+ proliferating cells. On day 16, the density of proliferating
cells treated with Gel/ORM had increased further (Fig. 5, A and C).
Continuous oxygenation and ROS scavenging also increased the
skin cell metabolic rate, as judged by the peroxisome proliferator–
activated receptor gamma coactivator 1  (PGC1) positive cell
density (Fig. 5, B and D) (44). Compared with the No treatment
group, the Gel group exhibited a significantly higher density of
PGC1+ cells. The release of oxygen in the Gel/ORM group further
increased the PGC1+ cell density at both time points.

SCIENCE ADVANCES | RESEARCH ARTICLE

groups showed similar densities of ROS+ cells (P > 0.05; Fig. 6,
A and C), demonstrating that the hydrogel can efficiently scavenge
ROS even if continuous oxygenation induces ROS formation.
To elucidate the impact of continuous oxygenation and ROS
scavenging on the inflammatory response in diabetic wounds, we
evaluated inflammatory cell density in the tissue by CD86 staining.
The CD86+ inflammatory cell density in the Gel and Gel/ORM
groups was significantly lower than in the No treatment group
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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(with P < 0.001 on day 8 and P < 0.05 on day 16; Fig. 6, B and D).
Notably, the Gel and Gel/ORM groups had similar inflammatory
cell densities. These results demonstrate that ROS scavenging by the
hydrogel decreased diabetic wound inflammation.
To further reveal the role of released oxygen in tissue inflammation, we assessed proinflammatory cytokine expressions in diabetic
wounds (Fig. 6, E and F). Compared with the Gel group, the Gel/ORM
group exhibited reduced expression of various proinflammatory
7 of 14
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Fig. 5. Continuous oxygenation and ROS scavenging promote cell proliferation and metabolism and stimulate angiogenic growth factor expression and angiogenesis in diabetic wounds. (A) Immunofluorescence staining of Ki67 (red) in the wounded region at 8 and 16 days after wounding. Scale bars, 50 m. (B) Immunofluorescence staining of PGC1 (green) in the wounded region at 8 and 16 days after wounding. Scale bars, 50 m. (C) Quantification of Ki67+ cell density. (D) Quantification
of PGC1+ cell density. (E and F) Gene expression of Pdgfb (E) and Vegfa (F) from the tissue lysates extracted from the wounded skin at day 8. n ≥ 4. (G) Immunofluorescence staining of isolectin (green) in the wounded region at 8 and 16 days after wounding. Scale bars, 50 m. Nuclei were stained with DAPI in all immunofluorescence
staining images. (H) Quantification of vessel density. *P < 0.05, **P < 0.01, and ***P < 0.001.
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cytokines, such as interleukin-1 (IL-1), tumor necrosis factor–
(TNF-), interferon- (IFN-), and chemokine ligand 1(CXCL1).
These results suggest that continuous oxygenation has the potential
to decrease inflammation during diabetic wound healing.
Continuous oxygenation in diabetic wounds up-regulated
phosphorylated Erk1/2 and HO-1 expressions
After showing that the oxygenation of keratinocytes by released
oxygen up-regulated phosphorylated Erk1/2 (p-Erk1/2) and HO-1
expressions in vitro, we next evaluated whether continuous oxygenation up-regulated these expressions in diabetic wounds. Consist
ent with the in vitro findings, the p-Erk1/2 and HO-1 expressions
were substantially up-regulated in the Gel/ORM group on days 8
and 16 (Fig. 7).
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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DISCUSSION

Chronic hypoxia is a main characteristic of diabetic wounds and a
severe impediment to the healing process. Consequently, sustained
oxygenation of skin cells to mitigate chronic hypoxia represents an
approach to accelerating diabetic wound healing. Oxygen therapy is
advantageous over drug therapy because it raises fewer toxicity concerns (45). However, current oxygen therapy approaches cannot
provide sufficient oxygen to metabolic-demanding skin cells long
enough to promote diabetic wound healing (46–48). In this work,
we developed an oxygen-release system that continuously oxygenates
diabetic wounds. It is composed of ORMs and their carrier, an
injectable, thermosensitive, fast-gelling, and ROS-scavenging hydrogel.
The ORMs have a core-shell structure, with PVP/H2O2 complex as
the core and a bioeliminable polymer as the shell. The high–molecular
8 of 14
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Fig. 6. Continuous oxygenation and ROS scavenging alleviate oxidative stress, inflammation, and proinflammatory cytokine expression in diabetic wounds.
(A) Immunofluorescence staining of CM-H2DCFDA (red) at the wounded site at days 8 and 16. Scale bars, 50 m. (B) Immunofluorescence staining of CD86 (red) at the
wounded site at days 8 and 16. Scale bars, 50 m. Nuclei were stained with DAPI in all immunofluorescence staining images. (C) Quantification of ROS+ cell density. The
results were normalized to the ROS+ cell density in No treatment group at day 8. n ≥ 8. (D) Quantification of CD86+ cell density. *P < 0.05 and ***P < 0.001. (E) Cytokine
array analysis of the proinflammatory cytokine level in the wounds 8 days after treatment. (F) Quantitative summary of cytokine array analysis in (E). A.U., arbitrary units.
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Fig. 7. ORMs activate HO-1 and Erk1/2 pathways. Immunoblotting of HO-1 and
p-Erk1/2 from the tissue lysates extracted from wounded skin at days 8 and 16 after
wounding. t-Erk1/2 was used as the internal reference. GAPDH was used as a loading control.
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weight PVP/H2O2 complex reduces H2O2 diffusivity, allowing for
sustained release of H2O2 during the hydrolysis of the shell polymer
(49, 50). The ORM surface is conjugated with catalase to timely
convert H2O2 in the released PVP/H2O2 into molecular oxygen
(Fig. 1A). Therefore, the ORMs can directly release oxygen (Fig. 1E),
whereas most other oxygen-release systems directly release H2O2
instead of oxygen (20, 51, 52). We demonstrated that the microspheres
could release oxygen for at least 2 weeks (Fig. 1E), longer than most
other oxygen-release systems (20, 22). The injectable, thermosensitive,
and fast-gelling hydrogel used as the ORM carrier largely retained
the ORMs in the diabetic wounds after delivery. The ROS-scavenging
hydrogel both eliminates the H2O2 in the released PVP/H2O2, even
if it is not completely converted by catalase, and captures the
up-regulated H2O2 in diabetic wounds to decrease oxidative stress
and accelerate wound healing. To the best of our knowledge, no
current oxygen-release system has been designed to release molecular
oxygen and scavenge ROS simultaneously.
We evaluated the efficacy and mechanism of action of the
oxygen-release system in healing excisional wounds in db/db mice
(Fig. 4A). This model exhibits significant delay in wound closure and
impaired wound bed vascularization compared with other well-accepted
murine diabetes models, such as streptozocin-induced C57BL/6J
and Akita mice (53). Our results showed that the oxygen-release
system substantially promoted wound closure (Fig. 4C). More
specifically, we sought to demonstrate that the accelerated wound
healing was caused by the sustained oxygenation and ROS scavenging
in diabetic wounds that augmented cell survival, accelerated cell
migration, stimulated angiogenesis, and reduced oxidative stress
and inflammation (Fig. 8).
First, we investigated the effect of oxygen released from ORMs
on skin cell survival in a hypoxic environment. We conducted in vitro
studies under 1% O2 and high-glucose conditions to mimic the
in vivo microenvironment in diabetic wounds (8, 54). The survival
of keratinocytes, fibroblasts, and endothelial cells under hypoxia
was significantly increased with the supplement of oxygen released
from the ORMs (Fig. 1, F to H). These three cell types are responsible
for epithelialization, wound contraction, and angiogenesis. In diabetic wounds, treatment with the oxygen-release system significantly
increased the density of proliferating cells (Fig. 5, A and C). The
augmented cell survival can be attributed to the elevated cellular
oxygen content (Fig. 2C). Cellular oxygen is essential for mitochondrial
metabolism, and the low oxygen level in diabetic wounds impairs
this process (55). The release of oxygen significantly increased the

mitochondrial metabolism of the cells in the wounds on day 8, as
evidenced by greater PGC1+ cell density (Fig. 5, B and D). Mechanistically, we found that the enhanced skin cell survival with released
oxygen is associated with the up-regulation of p-Erk1/2 in vitro and
in vivo (Figs. 2E and 7).
Next, we demonstrated that continuous oxygenation of skin cells
promoted the migration and paracrine effects of keratinocytes and
fibroblasts under hypoxia (Fig. 1, L to Q). The migration of these
cells is essential for the regeneration of the epidermis and dermis.
The enhanced paracrine effects, in terms of up-regulation of growth
factors such as VEGFA, FGF2, and PDGFB, facilitate the regeneration. Specifically, VEGFA and FGF2 have been found to increase
keratinocyte migration and proliferation (56–59). The up-regulated
expression of VEGFA, FGF2, and PDGFB in skin cells in response to
released oxygen may be attributed to increased p-Erk1/2 expression
(Fig. 2E). Previous studies have demonstrated that activation of
Erk1/2 pathway was able to up-regulate cell angiogenic growth factor
expression (60–62). The enhanced keratinocyte survival, migration,
and paracrine effects of continuous oxygenation led to a significant
increase in the wound closure rate (Fig. 4C) and formation of a
stratified epithelium (Fig. 4D).
Angiogenesis in diabetic wounds is essential for the regeneration
of the dermis. Although acute hypoxia induces angiogenesis mediated
by hypoxia-inducible transcription factors, chronic oxygen deprivation cannot sustain this process, thereby impairing the healing
process (6). We found that the released oxygen increased endothelial
cell survival (Fig. 1H) and tube formation (Fig. 1, R to T) in vitro. In
diabetic wounds, the continuous oxygenation significantly stimulated capillary formation (Fig. 5, G and H). The quicker angiogenesis
may also be attributed to the enhanced paracrine effects because the
expressions of angiogenic growth factors Pdgfb and Vegfa were
substantially up-regulated (Fig. 5, E and F).
Furthermore, we showed that the developed oxygen delivery system
alleviated oxidative stress in diabetic wounds (Fig. 6, A and C). The
decreased oxidative stress was due to the ROS-scavenging hydrogel
since the ROS+ cell densities in the Gel and Gel/ORM groups were
similar. This result minimizes potential concern that oxygen release
may lead to ROS overproduction. The decreased oxidative stress
may also be associated with increased HO-1 expression under
hypoxic conditions (Figs. 2E and 7). HO-1 has antioxidant effects
and has been reported to promote diabetic wound healing (63, 64).
Last, we showed that the oxygen-release system reduced inflammation in diabetic wounds (Fig. 6, B and D). Chronic wounds are
characterized by a high concentration of proinflammatory cells, the
major contributor of proinflammatory cytokines, such as TNF-,
IL-1, and CXCL1 (65). In addition, hyperglycemia exacerbates
inflammatory stress via the production of proinflammatory cytokines
such as TNF- (66). Our results show that ROS-scavenging hydrogel
greatly decreased the number of inflammatory cells (Fig. 6, B and D)
and the released oxygen further reduced the expression of major
proinflammatory cytokines (Fig. 6, E and F). Future studies will
focus on delineating signaling pathways as the underlying mechanism in suppressing inflammation by sustained oxygen release in
diabetic wounds.
Overall, we demonstrate in this report that a sustained oxygen-
release system that simultaneously scavenges ROS substantially
accelerated diabetic wound closure. The sustained release of oxygen had
multiple effects: It promoted skin cell survival, migration, and paracrine
effects; stimulated endothelial tube formation and angiogenesis;
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and decreased tissue inflammation. Compared with the results of
previous studies using growth factors or exogenous cells to treat
impaired wound healing in the same animal model, our oxygen-
release system exhibited faster (67–69) or similar wound closure
rates (70, 71). Thus, it represents an effective therapeutic approach
for accelerated healing of chronic diabetic wounds without using
drugs. Beyond wound healing, the developed oxygen-release system
may be used to treat other ischemic diseases, such as peripheral
artery disease and coronary heart disease. Given the limitations of
rodent models in illustrating more complex human pathophysiology,
we will further test our oxygen-release system in large animals
and optimize the oxygen-release kinetics and ROS-scavenging capability accordingly.
MATERIALS AND METHODS

Materials
All chemicals were purchased from MilliporeSigma unless otherwise
stated. NIPAAm (TCI) was recrystallized in hexane before use.
HEMA (Alfa Aesar) was used before passing through a column
filled with inhibitor removers. Benzoyl peroxide (BPO; Thermo
Fisher Scientific), acryloyl chloride, 4-(hydroxymethyl)-phenylboronic
acid pinacol ester, triethylamine (Fisher Scientific), PVP (40 kDa;
Fisher Scientific), hydrogen peroxide solution (30%), and bovine
liver catalase (2000 to 5000 U/mg) were used as received.

solution was precipitated in hexane. The polymer was purified twice
by dissolving in tetrahydrofuran and precipitating in ethyl ether.
The polymer was dissolved in DPBS at 4°C to make a 6 wt% solution.
The injectability of the 4°C solution with or without ORMs (40 mg/ml)
was tested by a 26-gauge needle (73, 74).
Hydrogel H2O2 responsiveness was characterized by its weight
loss after being incubated in H2O2 solution for 4 weeks. Briefly, the
hydrogel solution was solidified in 1.5 ml microcentrifuge tubes at
37°C. After the supernatant was discarded, 0.2 ml, 37°C DPBS with
or without 50 mM H2O2 was added. The samples were collected at
predetermined time points and freeze-dried. The weight loss was
calculated. To determine scavenging capability of the hydrogel for
hydroxyl radicals and superoxide, Fenton reaction assay (75) and
pyrogallol assay (76) were performed, respectively. Briefly, for Fenton
reaction assay, hydrogel solution or deionized (DI) water (control
group) was incubated with FeSO4, safranin O, and H2O2 for 5 min,
followed by heating at 55°C for 30 min. After the samples were
cooled to room temperature, the absorbance was measured at
492 nm using a microplate reader. For pyrogallol assay, the hydrogel
solution or DI water was mixed with tris-HCl. Pyrogallol solution
(3 mM) was then added dropwise in the dark. The reaction was
terminated by adding 8 M HCl. The absorbance was acquired
at 299 nm.

Cell survival on ROS-scavenging hydrogel
in the presence of H2O2
The ROS-scavenging hydrogel was plated on 96-well plates. HaCaT
Synthesis and characterization of ROS-scavenging hydrogel
4-(acryloxymethyl)-phenylboronic acid pinacol ester was synthesized cells (AddexBio) were seeded on the hydrogel surface at a density of
by the reaction between acryloyl chloride and 4-(hydroxymethyl)- 50,000 per well in optimized Dulbecco’s modified Eagle’s medium
phenylboronic acid pinacol ester (72). The ROS-scavenging hydrogel (DMEM, AddexBio) with 5% fetal bovine serum (FBS) and 1%
was synthesized by free radical polymerization of NIPAAm, HEMA, penicillin-streptomycin. After 24 hours of culture, the medium was
and 4-(acryloxymethyl)-phenylboronic acid pinacol ester using BPO discarded. A total of 200 l of 100 M H2O2-containing medium
as initiator and 1,4-dioxane as solvent. The reaction was conducted was added to each well. At 48 and 72 hours, the viability of HaCaT
at 70°C overnight with the protection of nitrogen. The polymer was measured by MTT assay. The non–ROS-responsive hydrogel,
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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Fig. 8. Mechanisms of accelerated wound healing by ORMs encapsulated in ROS-scavenging hydrogel. The ORMs and ROSS gel augmented cell proliferation and
migration, promoted angiogenesis and reepithelialization, and decreased inflammation and oxidative stress in diabetic wounds.
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poly(NIPAAm-co-HEMA-co-acrylate-oligolactide), was used as a
control (50, 74).

Oxygen-release kinetics
The ROS-sensitive hydrogel was dissolved in 4°C DPBS to make a
6 wt% solution. The ORMs were then mixed with the hydrogel solution at a concentration of 40 mg/ml. The oxygen-release kinetics
was determined by our established method (50, 74, 77). The wells of
a 96-well plate were covered by a polydimethylsiloxane membrane
loaded with an oxygen-sensitive luminophore Ru(Ph2phen3)Cl 2
and an oxygen-insensitive dye rhodamine B. Two hundred microliters
of the mixture was then added into each well (n = 8 for each group).
After gelation at 37°C, the supernatant was removed. A total of
200 l of DPBS preincubated in 1% oxygen condition was added. The
oxygen-release study was performed in 1% oxygen and 37°C conditions for 2 weeks. At each time point, the fluorescent intensity for
Ru(Ph2phen3)Cl2 was measured (emission at 610 nm and excitation
at 470 nm). The fluorescent intensity for rhodamine was also determined (emission at 576 nm and excitation at 543 nm) and used for
normalization. Oxygen concentration was determined by the calibration curve.
Cell survival, migration, and ROS content under hypoxia
HaCaT cells (AddexBio) were cultured in optimized DMEM
(AddexBio) with 5% FBS and 1% penicillin-streptomycin. HDF (Lonza)
were cultured in FGM-2 BulletKit (Lonza). HAEC (Cell Systems)
were cultured in EGM-2 BulletKit (Lonza). The medium was changed
every other day.
For all in vitro studies, cells were cultured using high-glucose
(450 mg/dl) and serum-free medium under 1% oxygen and 37°C
conditions. To determine cell survival, the cells were cultured in a
96-well plate using medium with or without ORMs (40 mg/ml,
n ≥ 5 for each group). The dsDNA content was measured using
Guan et al., Sci. Adv. 2021; 7 : eabj0153

27 August 2021

Interval at 0   
hour − interval at 48 hours  × 100%
migration ratio = ───────────────────────
   
Interval at 0 hour

To measure intracellular ROS content, the cells were prestained
with ROS-sensitive dye CM-H2DCFDA and cultured with serum-
free medium with or without ORMs (40 mg/ml). After 3 days of
culture for HaCaT cells and HAEC and 5 days of culture for HDF,
the cells were fixed and stained with 4′,6-diamidino-2-phenylindole
(DAPI). Fluorescent images were taken using a confocal microscope. The CM-H2DCFDA positive cell density was quantified
from at least 10 images for each group and then normalized to the
CM-H2DCFDA positive cell density cultured under normoxia.
Measurement of intracellular oxygen content
To determine the intracellular oxygen content, HaCaT cells were
incubated with lithium phthalocyanine nanoparticles for 2 hours to
allow cellular uptake. The residual nanoparticles were washed with
DPBS three times. After trypsinization, the cells were encapsulated
in the ROS-sensitive hydrogel or mixture of hydrogel and ORMs
(40 mg/ml). The samples were transferred into EPR tubes (Wilmad-
LabGlass, n = 3 for each group). The EPR tubes were opened on
both sides and placed in a hypoxic incubator (1% oxygen, 37°C) for
4 hours for complete gelation and gas balance. After that, the tubes
were sealed and incubated for 24 hours under 1% oxygen. The EPR
spectrum was recorded using an X-band EPR instrument (Bruker).
The parameters used in this experiment were 0.1 mW for microwave power, 1.0 dB for attenuation, and 9.8 GHz for frequency,
following our reported method (77, 78). Oxygen partial pressure (pO2)
was calculated from the linewidth of the spectrum and calibration
curve of linewidth versus oxygen concentration.
Measurement of intracellular ATP level
To determine the intracellular ATP level, HaCaT were cultured in a
six-well plate to reach 85 to 95% confluency. The culture medium
was then replaced with serum-free media with or without ORMs
(40 mg/ml). After 24-hour incubation under 1% O2, the cells were
lysed, and the ATP content was measured by an ATP assay kit as per
the manufacturer’s instruction (n = 3; MilliporeSigma).
Endothelial tube formation
HAECs were cultured in a 3D collagen model described previously
(28). Briefly, the model was prepared by mixing rat tail collagen
type I (Corning), FBS, DMEM, and NaOH. A total of 400 l of the
mixture was placed in a 48-well plate and incubated at 37°C for
30 min to allow the formation of jelly-like solid collagen gel. HAECs
were encapsulated in ROSS gel solution and injected into the collagen-
based 3D model at a density of 10,000 cells per well. After overnight
hypoxic culture, HAECs were fixed by 4% paraformaldehyde and
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Fabrication of ORMs and catalase conjugation
The ORMs were fabricated by double emulsion method. Briefly, the
shell of the microspheres was synthesized by the copolymerization
of NIPAAm, HEMA, NAS, and AOLA. The chemical structure of the
shell polymer was confirmed by 1H-NMR (proton nuclear magnetic
resonance) (fig. S1). The synthesized polymer was dissolved in
dichloromethane to form the 5 wt% oil phase. The inner water phase
was prepared by dissolving 242 mg of PVP in 1 ml, 30% H2O2 at
4°C overnight. The water phase was rapidly added into the oil phase
and sonicated by an ultrasonic liquid processor (Cole Parmer). The
primary water-in-oil emulsion was then poured into poly(vinyl
alcohol) solution to form the water-in-oil-in-water double emulsion.
The mixture was stirred for 3 hours to remove dichloromethane, followed by centrifugation to collect the microspheres. Morphology and
size of the microspheres were characterized by scanning electron
microscopy images. To confirm the core-shell structure, FITC and
rhodamine were added to the PVP/H2O2 solution and polymer/
dichloromethane solution, respectively. The fluorescent images were
acquired by a confocal microscope. To conjugate catalase onto the
microsphere shell, 40 mg microspheres were mixed with 6 ml catalase
solution (5 mg/ml in DI water) and stirred for 4 hours at 4°C. The
mixture was then centrifuged. The microspheres were washed three
times with DI water to remove unconjugated catalase. To confirm
the conjugation, the catalase was prelabeled by FITC, and the fluorescent images of the microspheres were taken after the conjugation.

PicoGreen dsDNA assay kit (Invitrogen) after 5 days of culture for
HaCaT cells and HDFs and after 7 days of culture for HAEC.
To perform cell migration assay, the cells were first cultured in a
six-well plate to reach 85 to 95% confluency (n = 4 for each group).
The monolayer was then scraped with a 200 l pipette tip, washed,
and supplemented with serum-free medium with or without ORMs
(40 mg/ml). After 48 hours, optical images were taken using an
optical microscope (Olympus IX70). The distances between two
sides of the scratch were measured using ImageJ. The migration
ratio was calculated as
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stained with DAPI and F-actin. Fluorescent images were taken as
z-stacks with a confocal microscope (Zeiss LSM 700).

Histological and immunofluorescence analyses
The wound tissues were fixed in 4% paraformaldehyde overnight,
embedded in paraffin, and serially sectioned at 5 m. Hematoxylin
and eosin staining was performed to measure the epidermal thickness in wounded skin. Epidermal thickness was calculated in the
wound closed region. Picrosirius red staining was used to quantify
the collagen deposition and collagen I/III ratio. For immunofluorescence analysis, following deparaffinization, antigen retrieval, and
blocking, the sections were incubated with primary antibodies,
including rabbit monoclonal anti–cytokeratin 10 (K10; Abcam, ab76318),
mouse monoclonal anti–cytokeratin 14 (K14; Abcam, ab7800), rabbit
monoclonal anti-CD86 (Abcam, ab234401), rat monoclonal anti-Ki67
(Invitrogen, SolA15), isolectin GS-IB4 (Invitrogen, I21411) (79), and
ROS indicator (CM-H2DCFDA; Invitrogen). The sections were
then incubated with corresponding secondary antibodies. Nuclei
were stained with DAPI. Quantification of the stainings was performed using ImageJ. At least six images for each group were used
for the quantification.
mRNA expression in in vitro cultured cells
and diabetic wounds
RNA was isolated from the in vitro cultured cells or wound tissues
using TRIzol following the manufacturer’s instruction. cDNA was
synthesized using a high-capacity cDNA reverse transcription kit
(Thermo Fisher Scientific). Gene expression was performed by
real-time RT-PCR using SYBR Green (Invitrogen) and selected
primer pairs (table S1). -Actin served as a housekeeping gene. Data
analysis was performed using the ∆∆Ct method.
Protein expression in in vitro cultured cells
and diabetic wounds
Protein lysates were collected from the in vitro cultured cells or wound
tissues and separated by SDS–polyacrylamide gel electrophoresis.
Low fluorescence polyvinylidene difluoride membranes (Bio-Rad)
were used to transfer the proteins at 4°C overnight, followed by
blocking and incubation with primary antibodies at 4°C. The blots
were washed with PBST (DPBS + 0.1% Tween 20) and incubated with
appropriate horseradish peroxidase–conjugated secondary antibodies.
Guan et al., Sci. Adv. 2021; 7 : eabj0153
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Statistical analysis
All data were presented as means ± SD. Statistical analysis was
performed between groups using one-way analysis of variance
(ANOVA) with Tukey’s post hoc test. A value of P < 0.05 was
considered statistically significant.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/35/eabj0153/DC1
View/request a protocol for this paper from Bio-protocol.
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Implantation of hydrogel and ORMs into diabetic wounds
All animal care and experiment procedures were conducted in
accordance with the National Institutes of Health guidelines. The
animal protocol was approved by the Institutional Animal Care and
Use Committee of Washington University in St. Louis. Eight-week
old, female db/db mice (BKS.Cg-Dock7m +/+ Leprdb/J) were
purchased from the Jackson laboratory. Blood glucose was measured
before surgery to ensure that the glucose level was higher than
300 mg/dl. After anesthetization and removal of hair, two full-thickness,
5-mm-diameter wounds on the dorsal skin were created for each
mouse using a biopsy punch. The hydrogel (6 wt% in DPBS) or Gel/ORM
(6 wt% in DPBS, microspheres at 40 mg/ml) was topically administrated. Digital images of the wounds (n ≥ 8 for each group) were taken
every other day, and the wound size was determined using ImageJ.
After 8 and 16 days of implantation, the mice were euthanized. The wound
tissues were collected for histological and immunofluorescence
analysis and RNA and protein isolation.

Immunoblots were detected using a detection kit from Advansta
and imaged using ChemiDoc XRS+ System (Bio-Rad). The primary
antibodies used were anti–glyceraldehyde-3-phosphate dehydrogenase
(1:4000; Abcam, ab8245), anti–HO-1 (1:500; Abcam, ab52947),
anti–p-Erk1/2 (1:500; Cell Signaling Technology, #9101), and anti–
t-Erk1/2 (1:1000; Cell Signaling Technology, #4695).
For protein array assay, wounded tissue lysates were collected
and tested using Proteome profiler mouse cytokine array kit
(R&D Systems) according to the manufacturer’s instructions. The
pixel density was quantified using Image Lab software (Bio-Rad) (80).
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